Alpha blocker

The World

Geneticists solve a beta blocker puzzle

Environment

It was a medical enigma: Why do many black patients respond differently to a class of heart drugs called beta blockers? Researchers now say a genetic variant allows 40 percent of black patients to produce their own version of the drugs. Dr. Stephen Liggett tells The Takeaway about his study and the potential impacts on health care.

Tell us about your experience accessing The World

We want to hear your feedback so we can keep improving our website, theworld.org. Please fill out this quick survey and let us know your thoughts (your answers will be anonymous). Thanks for your time!

We respect your time, attention and privacy

This is a news website, not a click casino. We do NOT employ deceptive behaviors, display annoying ads or use third party cookies and trackers to monetize your visit or help advertisers track you across the internet.

Simply, we ask that you would consider a donation to support the journalism we produce every weekday. Thank you.